When to Start Insulin in Type 2 Diabetes
Initiate insulin therapy immediately in patients with newly diagnosed T2DM when HbA1c ≥9% or fasting glucose ≥11.1 mmol/L (≥200 mg/dL), especially if symptomatic hyperglycemia or catabolic features are present. 1, 2
Immediate Insulin Initiation Criteria
For severe hyperglycemia at diagnosis:
- Start insulin when random blood glucose consistently exceeds 300 mg/dL (16.7 mmol/L), combined with metformin and lifestyle modifications 1
- Begin insulin when HbA1c ≥10-12% with symptomatic hyperglycemia or catabolic features (weight loss, polyuria, polydipsia) 3, 1
- This approach allows rapid glucose normalization and gives beta cells a chance to "rest and recover" 1
Short-term intensive insulin therapy (2 weeks to 3 months):
- Implement in newly diagnosed patients with HbA1c >9.0% or fasting glucose ≥11.1 mmol/L with symptomatic hyperglycemia 3, 2
- Use basal insulin (glargine or detemir) at 0.2-0.3 units/kg/day, given once daily at bedtime 1
- Taper insulin after glucose control is achieved, typically within 2 weeks to 3 months 1, 2
Delayed Insulin Initiation (After Oral Agent Failure)
When oral medications fail to achieve glycemic targets:
- Add insulin when HbA1c remains above target after 3 months of optimal oral medications and lifestyle modifications 3, 1, 4
- Consider insulin at HbA1c ≥9%, with definite consideration at ≥10-12% 1
- Insulin is essential when HbA1c ≥10% (≥86 mmol/mol) despite optimized diet, physical activity, and other antihyperglycemic agents 4
The 3-month rule:
- Patients not achieving glycemic goals with lifestyle intervention and oral agents should initiate insulin as soon as possible, ideally within 3 months of recognized treatment failure 3, 2
Practical Implementation
Initial insulin regimen:
- Start with basal insulin (NPH, glargine, detemir, or degludec) as the preferred initial approach 3, 5
- For insulin-naïve patients inadequately controlled on oral agents, begin at 0.1-0.2 units/kg once daily in the evening or 10 units once or twice daily 6, 5
- Alternative: Premixed insulin 1-3 times daily for patients requiring more comprehensive coverage 3, 4
Continue metformin:
- Metformin should be continued unless contraindicated, as it reduces all-cause mortality, cardiovascular events, weight gain, insulin dose requirements, and hypoglycemia risk 1, 7
- Start metformin at 500 mg once daily with dinner, increasing by 500 mg every 1-2 weeks up to 2000 mg daily in divided doses 1
Titration Strategy
Dose adjustment protocol:
- Titrate insulin every 3-4 days based on fasting glucose targets (80-130 mg/dL) 1, 5
- Increase by 2-4 units every 3 days until fasting glucose of 80-130 mg/dL is reached 1
- Prophylactic titration algorithm: fasting glucose <4.4 mmol/L: -2U; 4.4-7.0: +0U; 7.1-10.0: +2U; >10.0: +4U 8
Monitoring requirements:
- Self-monitor blood glucose with fasting and 2-hour post-meal readings daily while on insulin 1
- Check HbA1c at 3 months to assess response 1
- Weekly follow-up initially to titrate insulin and assess for hypoglycemia 1
Target Goals
Glycemic targets:
- HbA1c <7% for most patients 1, 5
- Fasting glucose 80-130 mg/dL 1, 5
- 2-hour post-meal glucose <180 mg/dL 1, 5
Common Pitfalls to Avoid
Do not delay insulin unnecessarily:
- The progressive nature of T2DM means many patients will eventually require insulin 3
- Avoid using insulin as a threat or describing it as failure or punishment 3
- Providers should regularly and objectively explain the progressive nature of T2DM to patients 3
Do not abruptly discontinue oral medications:
- Oral medications should not be stopped abruptly when starting insulin due to risk of rebound hyperglycemia 4
- Continue metformin specifically for its mortality and cardiovascular benefits 1, 7
Watch for hypoglycemia and weight gain: